Advanced search×

In Reply

M H Kulke and C S Fuchs

J Clin Oncol 27(2):320-320 (2009)

DOI: 10.1200/JCO.2008.20.3240
Version: za2963e q8zab q8zb9 q8zcc q8zd3 q8ze8 q8zf6 q8zg9

Similar articles you may find interesting…

  1. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcino...
    Jonathan R Strosberg, Domenico Coppola, ... North American Neuroendocrine Tumor Society (NANETS)

    Pancreas 39(6):799-800 (2010) PMID 20664477

    Extrapulmonary poorly differentiated neuroendocrine carcinomas can originate in the gastrointestinal tract, bladder, cervix, and prostate. These high-grade malignancies are characterized by aggressive histological features (high mitotic rate, extensive necrosis, and nuclear atypia) and a poor clinic...
    View PDF
  2. A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors...
    Matthew H MH Kulke, Jennifer A JA Chan, ... Charles S CS Fuchs

    Cancer Chemother Pharmacol 68(2):293-300 (2011) PMID 20960192

    The combination of 2ME2 and bevacizumab was relatively easily tolerated and was associated with anticipated toxicities for these two agents. No confirmed radiologic responses (by RECIST) were observed. However, 68% of the radiologically evaluable patients experienced at least some degree of tumor re...